NCT05707429

Brief Summary

Sexual dysfunction \[SD\] is a significant health burden characterized by a disturbance in sexual desire and psychophysiological changes in the sexual response cycle, resulting in marked distress and interpersonal difficulty (4). As known, both SD and depression are interrelated, so, depression may be an important determinant of sexual functioning in patients with IBD(5).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 14, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

March 19, 2024

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

January 14, 2023

Last Update Submit

March 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • inactive IBD &sexual function of both males

    using questionnaire IIEF-5 score It consists of five questions, including vaginal penetration, maintenance of erection, completion of intercourse, sexual satisfaction, and self-confidence of the patient's sexual arousal and maintenance of an erection * A total score of \< 22 is defined as ED . females using FSFI score. * The optimal cutoff score of the FSFI is 26.55, which means that a score at or below this value is defined as female SD

    3 months

Secondary Outcomes (1)

  • Mean scores for quality of life among inactive IBD patients

    3 months

Study Arms (2)

Healthy control group

will include patient's relatives or volunteers, who accept to participate in the study through invitation or posters which send or spread it to all staff hospitals about importance of the study.

Other: The Arabic version of The International Index of Erectile Function (IIEF-5)Other: The Sexual Quality of Life Questionnaire Male/Female (SQoL M/F)Other: Assessment of depression and anxietyOther: The Fatigue assessment scale (16)Other: • Quality of life assessmentOther: The Female Sexual Function Index (FSFI)

IBD patients inactive group

IBD patients group: they will be recruited from outpatient clinic and inpatient with CD or UC at the Gastroenterology department at Alrajhi hospital. CD patients will be assessed by the Crohn's Disease Activity Index a score of less than 150 corresponds to relative disease quiescence (remission); 150 to 219, mildly active disease; 220 to 450, moderately active disease; and greater than 450, severe disease (9).

Other: The Arabic version of The International Index of Erectile Function (IIEF-5)Other: The Sexual Quality of Life Questionnaire Male/Female (SQoL M/F)Other: Assessment of depression and anxietyOther: The Fatigue assessment scale (16)Other: • Quality of life assessmentOther: The Female Sexual Function Index (FSFI)

Interventions

The Arabic version of The International Index of Erectile Function A self-administered questionnaire that assesses 5 dimensions of sexual function over the most recent 4 weeks. It consists of five questions, including vaginal penetration, maintenance of erection, completion of intercourse, sexual satisfaction, and self-confidence of the patient's sexual arousal and maintenance of an erection. A total score of \< 22 is defined as ED .

Healthy control groupIBD patients inactive group

was developed by Symonds et al.,(14) which assesses subjects' feelings toward their sexuality (ranging from 0% to 100%, with higher scores indicating higher SQoL). The SQoL M/F was developed as a condition-specific QoL questionnaire to test the relationship between sexual symptoms and other aspects of general health and sexual QoL.

Healthy control groupIBD patients inactive group

Arabic version of Hamilton depression and anxiety rating scale (15): used to measure the severity of anxiety and depressive symptoms, and is widely used in both clinical and research settings.

Healthy control groupIBD patients inactive group

It is a 10-item self-report scale evaluating symptoms of fatigue. The FAS treats fatigue as a unidimensional construct and does not separate its measurement into different factors. However, in order to ensure that the scale evaluates all aspects of fatigue, it measures both physical and mental symptoms. The total score ranges from 10 to 50, with a higher score indicating more severe fatigue.

Healthy control groupIBD patients inactive group

Health related quality of life (HRQoL measure): using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) (17), which assesses physical, social, and emotional domains of IBD patients' lives (scores range from 10-70, with higher scores indicating better HRQoL) The SIBDQ reflects relevant clinical changes in both CD and UC.

Healthy control groupIBD patients inactive group

The FSFI includes such parameters as desire, arousal, lubrication, orgasm, satisfaction, and pain. The optimal cutoff score of the FSFI is 26.55, which means that a score at or below this value is defined as female SD.

Healthy control groupIBD patients inactive group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Will include 2 groups: IBD patients inactive group and healthy control group. IBD patients group: they will be recruited from outpatient clinic and inpatient with CD or UC at the Gastroenterology department at Alrajhi hospital. Healthy control group: will include patient's relatives or volunteers, who accept to participate in the study through invitation or posters which send or spread it to all staff hospitals about importance of the study. All participants will subject to

You may qualify if:

  • years old.
  • Both sexes
  • A stable sexual partner for ≥3 months
  • ability to fill in and understand the questionnaire
  • sign informed consent and participate voluntarily. For control group: An age-matched control group of healthy men and women, in the same region will also be invited to participate. The controls will eligible if they are 18-50 years of age, have a stable heterosexual relationship for at least 3 months and do not have bowel like IBD or irritable bowel syndrome or psychiatric problems.

You may not qualify if:

  • Those who couldn't understand or fill out the questionnaire themselves and/or those with mental disorders
  • Diagnosis of SD before an IBD diagnosis
  • SD compounded by other diseases: cardiovascular and cerebrovascular diseases, lung diseases, liver and kidney dysfunction, diabetic neuropathy, other psychiatric disorders (e.g. depression), and neoplastic diseases, etc.
  • History or current use of psychotropic drugs or medications have sexual side effects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Egypt

Location

MeSH Terms

Conditions

Sexual Dysfunctions, PsychologicalInflammatory Bowel Diseases

Condition Hierarchy (Ancestors)

Mental DisordersGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Study Officials

  • ahmed mahmoud abd ella hassan, MD

    Assiut university ,andrology departement

    STUDY CHAIR
  • mostafa Mohammed Hashem, MD

    Assiut University

    STUDY DIRECTOR
  • ahmed abdelfadeel maghrapy, MD

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

January 14, 2023

First Posted

February 1, 2023

Study Start

February 1, 2023

Primary Completion

August 1, 2023

Study Completion

February 1, 2024

Last Updated

March 19, 2024

Record last verified: 2024-03

Locations